arrow_back Back to App

New Law: Mifepristone Warning Label and Reversal Hotline

This proposed law aims to provide women with more information and support regarding a specific medication, mifepristone. It would require a warning label on the drug about potential ways to counteract its effects and establish a 24/7 hotline for women seeking such information. This could impact women's choices and access to information concerning medical abortion.
Key points
Drug manufacturers would need to add a warning label to mifepristone, stating that its effects might be counteracted by natural progesterone to increase fetal survival.
A new, free, 24-hour hotline would be created to offer support and information to women interested in reversing the effects of mifepristone.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_7823
Sponsor: Rep. Miller, Mary E. [R-IL-15]
Process start date: 2024-03-26
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Second Chance for Moms Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_7823.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2024-03-26.

What are the main provisions?

Key points include:

  • Drug manufacturers would need to add a warning label to mifepristone, stating that its effects might be counteracted by natural progesterone to increase fetal survival.
  • A new, free, 24-hour hotline would be created to offer support and information to women interested in reversing the effects of mifepristone.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller, Mary E. [R-IL-15].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-13.

CATEGORIES

Health